Avadel Pharmaceuticals PLC (AVDL) — Capital Reinvestment Ratio
Avadel Pharmaceuticals PLC (AVDL) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($23.26 Million) in capital expenditures ($10.76K). Check tangible net worth ratio of Avadel Pharmaceuticals PLC to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Avadel Pharmaceuticals PLC Capital Reinvestment Ratio (2002–2017)
This chart tracks Avadel Pharmaceuticals PLC's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Avadel Pharmaceuticals PLC (AVDL) cash conversion ratio.
Annual Capital Reinvestment Ratio for Avadel Pharmaceuticals PLC (2002–2017)
Year-by-year Capital Reinvestment Ratio for Avadel Pharmaceuticals PLC from 2002 to 2017. See AVDL FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 3.22x | $16.66 Million | $53.70 Million | ▲ +4972.3% |
| 2016 | 0.06x | $18.90 Million | $1.20 Million | ▲ +228.8% |
| 2015 | 0.02x | $84.29 Million | $1.63 Million | ▼ -91.1% |
| 2009 | 0.22x | $8.20 Million | $1.77 Million | ▼ -7.0% |
| 2003 | 0.23x | $12.23 Million | $2.84 Million | ▲ +42.0% |
| 2002 | 0.16x | $8.77 Million | $1.44 Million | — |